HITS
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- $4.6M
Investors
- 6
About HITS
HITS Inc. is a South Korean biotechnology firm specializing in the innovative use of artificial intelligence to develop pharmaceuticals, enhancing drug discovery processes through advanced technology. Founded in 2020 in Seoul, South Korea, HITS Inc. focuses on leveraging AI technologies for pharmaceutical development. Jaechang Lim, the founder, has previously engaged in other entrepreneurial ventures, although specific details of those are not provided. HITS Inc. specializes in the innovative development of pharmaceuticals through advanced artificial intelligence technologies. It offers a deep learning-integrated virtual exploration system that accelerates the identification of effective compounds, supported by a proprietary virtual library that protects intellectual property. The company employs a molecular pharmacology-inspired design patent technique to optimize new molecular structures across various modalities, including small molecules and peptidomimetics. HITS Inc. serves clients in the pharmaceutical and biotech industries globally, particularly in North America, Europe, and Asia. HITS Inc. generates revenue through B2B partnerships and direct collaborations with pharmaceutical companies and research institutions.'s proprietary technologies and access to its virtual library and predictive models for drug development, utilizing subscription-based or project-based pricing structures tailored to the complexity of the services offered. HITS Inc. plans to enhance its product offerings by continuing to develop its AI-driven technologies aimed at further improving drug discovery processes. The company is also exploring expansion into new markets, focusing on opportunities in North America and Europe by 2024.
Who invested in HITS
6 investors across 2 rounds
See all investors in HITS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HITS
Who invested in HITS?
HITS has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HITS raised?
HITS has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HITS last raise money?
HITS's most recent round on record is a Series A, in Feb 2022.
What does HITS do?
HITS is a pharmaceuticals company.
Where is HITS headquartered?
HITS is headquartered in Seoul, South Korea.
Which VCs invest in companies like HITS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at HITS's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like HITS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.